e-learning
resources
Barcelona 2010
Wednesday, 22.09.2010
Exercise in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Exercise intolerance and lung emphysema in alpha-1 antitrypsin deficiency (AATD)
L. Vaz-Rodrigues, F. Costa, C. Mendonça (Coimbra, Portugal)
Source:
Annual Congress 2010 - Exercise in COPD
Session:
Exercise in COPD
Session type:
E-Communication Session
Number:
5405
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Vaz-Rodrigues, F. Costa, C. Mendonça (Coimbra, Portugal). Exercise intolerance and lung emphysema in alpha-1 antitrypsin deficiency (AATD). Eur Respir J 2010; 36: Suppl. 54, 5405
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Imaging of complicated pneumonia: what is new?
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Lung function in relation to emphysema development in alpha-1 antitrypsin deficiency
Source: International Congress 2019 – Insights into physiological diagnostic services
Year: 2019
Alpha-1 antitrypsin deficiency in patients with COPD/emphysema, bronchiectasis and asthma
Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases
Year: 2020
Screening for alpha-1 antitrypsin deficiency in Polish lung or liver disease patients
Source: Annual Congress 2011 - Lung development and neoplasia
Year: 2011
COPD and alpha-1 antitrypsin deficiency emphysema: characteristics and survival after Lung Transplantation
Source: International Congress 2018 – Moving lung transplantation forward
Year: 2018
Immune activation in α1 antitrypsin deficiency (AATD) emphysema: Beyond the protease/antiprotease hypothesis
Source: Annual Congress 2012 - Mechanistic studies in airway cell biology
Year: 2012
Alpha 1 antitrypsin (A1AT) deficiency among patients with cystic fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 501s
Year: 2003
Comparison of exercise training responses in COPD patients with and without Alpha-1 antitrypsin deficiency
Source: International Congress 2018 – Latest advances in pulmonary rehabilitation assessment and content
Year: 2018
Bronchiectasis but not emphysema is more prevalent in non-PiZ alpha-1 antitrypsin deficiency (AATD) COPD than in usual COPD
Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD
Year: 2014
Regional deposition of
99m
Tc-labelled alpha-1 antitrypsin (AAT) in patients with alpha-1 antitrypsin deficiency and cystic fibrosis (CF) compared with healthy volunteers
Source: Annual Congress 2007 - Cystic fibrosis: the balance between treatment and side-effects
Year: 2007
Endobronchial valve treatment in patients with severe emphysema due to alpha-1 antitrypsin deficiency.
Source: International Congress 2019 – Interventional pulmonology: diagnostic techniques and obstructive airway disease
Year: 2019
Patterns of exacerbations in alpha 1 antitrypsin deficiency (AATD)
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
Functional alterations of small airways in patients with alpha-1 antitrypsin deficiency (AATD) in a longitudinal study
Source: Eur Respir J 2005; 26: Suppl. 49, 361s
Year: 2005
Relationship between atopy, asthma and alpha-1 antitrypsin deficiency
Source: International Congress 2019 – Clinical aspects of airway diseases
Year: 2019
Substitution therapy in Alpha-1 antitrypsin deficiency after lung transplantation
Source: Eur Respir J 2006; 28: Suppl. 50, 724s
Year: 2006
Alveolar nitric oxide correlates with lung volumes in patients with emphysema and Alpha-1 antitrypsin deficiency (AATD)
Source: Eur Respir J 2006; 28: Suppl. 50, 223s
Year: 2006
Association between alpha1 antitrypsin (AAT) circulating polymers (CP) and lung and liver disease in patients with AAT deficiency (AATD).
Source: Virtual Congress 2021 – Molecular pathology and cell biology of pulmonary diseases
Year: 2021
Intra-epithelial polymerization, accumulation and secretion of alpha
1
antitrypsin (AAT) Z polymers in the lung of patients with alpha-1 antitrypsin deficiency (AATD)
Source: Annual Congress 2010 - Epithelial cell biology
Year: 2010
Alpha-1 antitrypsin deficiency severity and the risk of COVID-19
Source: Virtual Congress 2021 – Burden and epidemiology of COVID-19
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept